JAKARTA - Extraordinary General Meeting of Shareholders (EGMS) of PT Kimia Farma (Persero) Tbk (KAEF) approved the plan to conduct a rights issue by releasing 178,947,368 of series B shares. The EGMS itself took place on Thursday (18/9).
According to the disclosure of company information, shareholders give the authority to Kimia Farma's management to decide the exact number of shares to be issued in a rights issue. So far, the date and use of funds from the rights issue has not been submitted by the management.
According to its financial report, KAEF's cash and cash equivalents were recorded at Rp 371.68 billion, lower than its position to 31 December 2018 of Rp 2.06 trillion. (LK/AR)